Newron Pharmaceuticals Azioni (OTC: NWPHF)

Ultime notizie per Newron Pharmaceuticals (OTC:NWPHF) Azioni

Newron Pharmaceuticals SpA is a Italy-based clinical-stage biopharmaceutical company. It focuses on the discovery and development of pharmaceutical products. The Company is engaged in discovering and developing new therapies for diseases of the Central Nervous System (CNS) and pain. The Company undertakes phase III trials with safinamide molecule for the treatment of patients with Parkinson's disease. Newron Pharmaceuticals SpA develops ralfinamide, a molecule for the treatment of neuropathic pain. Geographically the research and development activities are performed in Italy and the United States.

NEWRON PHARMS SPA ORD by Newron Pharmaceuticals SPA

Comments

Newron Pharmaceuticals

Notizie

Ultime notizie per Newron Pharmaceuticals (OTC:NWPHF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO